Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

NCT05636592 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: immunotherapy

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Collaborators

[object Object]